Earth Science Tech, Inc. (ETST): Depreciation & Amortization

Annual figures by period end, from SEC filings.

$284.4K

Year ended 2026-03-31

$316.7K

Trailing 12 months to 2026-06-30

+153.3%

3-year compound annual growth

2023-03-31 Depreciation & Amortization (USD) 2026-03-31

Period ended	Depreciation & Amortization	Change YoY	Source filing
2026-03-31	$284.4K	+427.1%	2026-06-18, From 2025-04-01
2025-03-31	$54.0K	-64.0%	2026-06-18, From 2024-04-01
2024-03-31	$149.7K	+756.1%	2025-06-27, From 2023-04-01
2023-03-31	$17.5K	n/a	2024-06-28, From 2022-04-01

Depreciation & Amortization at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Depreciation & Amortization	Change YoY
Earth Science Tech, Inc. (ETST)	2026-03-31	$284.4K	+427.1%
Sunshine Biopharma Inc. (SBFM)	2025-12-31	$332.1K	+48.6%
Lftd Partners Inc. (LIFD)	2025-12-31	$552.9K	+6.2%
Bioharvest Sciences Inc. (BHST)	2025-12-31	$1.62M	+29.8%
BGM Group Ltd. (BGM)	2025-09-30	$1.46M	+18.3%
Foghorn Therapeutics Inc. (FHTX)	2025-12-31	$3.33M	+6.8%
Biofrontera Inc. (BFRI)	2025-12-31	$138.0K	-67.2%
Xilio Therapeutics, Inc. (XLO)	2025-12-31	$1.54M	-6.3%
Cumberland Pharmaceuticals Inc (CPIX)	2025-12-31	$4.15M	-15.4%

Compare ETST, SBFM, LIFD, BHST side by side · Screen every company in Pharmaceutical Preparations ↗